Development and validation of a flexible DNA extraction (PAN) method for liquid biopsy of multiple sample types-Reference-Cited by-同舟云学术

Development and validation of a flexible DNA extraction (PAN) method for liquid biopsy of multiple sample types

Published:2021-08-16 Issue:9 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Chen Xiao‐Xia¹,Chen Wei²,Liu Yi‐Long¹,Lin Can‐Xiang³,Li Mengmeng¹,Chen Wen‐Jie¹,Xie Shang‐Hang¹⁴,Lin Dong‐Feng¹,Cao Su‐Mei¹⁴

Affiliation:

1. Department of Cancer Prevention Research Sun Yat‐sen University Cancer Center Guangzhou China

2. Department of Pathology The Seventh Affiliated HospitalSun Yat‐sen University Shenzhen China

3. Department of Plastic Surgery The First Affiliated Hospital of Jinan University Guangzhou China

4. State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, and Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Sun Yat‐Sen University Cancer Center Guangzhou China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23962

Reference73 articles.

1. Application of liquid biopsy in precision medicine: opportunities and challenges

2. Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers

3. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids

4. Multitarget Stool DNA Testing for Colorectal-Cancer Screening

5. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin